OpenVSafe by OpenVAERS
Search V-safe

M45-32356-98076

3 vaccinations 3 coded responses 21 check-ins 0 free-text entries 0 call cases
Sex
Male
Age at first dose
05-11
ZIP prefix
284 / NC
Registered
2021-12-17
Relationship
Child or adolescent in my care
Guardian
FM6-11436-98746
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-12-15
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-17
    Registered in v-safe
  3. 2021-12-17
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  4. 2021-12-18
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  5. 2021-12-19
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-12-20
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-12-21
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-12-22
    Health check-in — day 7, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  9. 2021-12-29
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  10. 2022-01-05
    Dose 2 — Pfizer-BioNTech
  11. 2022-01-21
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2022-01-26
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  13. 2022-02-02
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  14. 2022-02-09
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  15. 2022-02-16
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  16. 2022-04-06
  17. 2022-07-06
  18. 2023-01-07
  19. 2023-01-09
    Dose 3 — Moderna
  20. 2023-01-23
    Survey response — day 14, dose 3, dependent
    MedDRA: Oropharyngeal pain, Pain, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  21. 2023-01-30
    Survey response — day 21, dose 3, dependent
    MedDRA: Oropharyngeal pain, Pyrexia, Sinusitis, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  22. 2023-02-06
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  23. 2023-02-13
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  24. 2023-02-22
    Survey response — day 42, dose 3, dependent
    MedDRA: Respiratory tract congestion — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11
  25. 2023-04-10

Vaccinations

DoseDateManufacturerCo-administered
12021-12-15Pfizer-BioNTech No
22022-01-05Pfizer-BioNTech No
32023-01-09Moderna No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDSinusitis · · ✓
SDViral infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release